Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Adri Recio"'
Autor:
Steven M. Albelda, Corey J. Langer, Melissa Culligan, Charles B. Simone, Keith A. Cengel, Luis J. Montaner, Paul Kennedy, Emmanouil Papasavvas, Kay See Tan, Jennifer H. Yearley, Leslie Litzky, Wei-Ting Hwang, Daniel F. Heitjan, Jing Sun, Sharyn I. Katz, Anil Vachani, Andrew R. Haas, Edmund K. Moon, Adri Recio, Susan Metzger, Joseph Friedberg, James P. Stevenson, Evan Alley, Daniel H. Sterman
Purpose: “In situ vaccination” using immunogene therapy has the ability to induce polyclonal antitumor responses directed by the patient's immune system.Experimental Design: Patients with unresectable malignant pleural mesothelioma (MPM) received
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2810b59165230c7ab9401119d8a2979b
https://doi.org/10.1158/1078-0432.c.6523496.v1
https://doi.org/10.1158/1078-0432.c.6523496.v1
Autor:
Steven M. Albelda, Corey J. Langer, Melissa Culligan, Charles B. Simone, Keith A. Cengel, Luis J. Montaner, Paul Kennedy, Emmanouil Papasavvas, Kay See Tan, Jennifer H. Yearley, Leslie Litzky, Wei-Ting Hwang, Daniel F. Heitjan, Jing Sun, Sharyn I. Katz, Anil Vachani, Andrew R. Haas, Edmund K. Moon, Adri Recio, Susan Metzger, Joseph Friedberg, James P. Stevenson, Evan Alley, Daniel H. Sterman
Legends for the Supplementary Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41ba458e4ae14f893689b0ac6a00f221
https://doi.org/10.1158/1078-0432.22457063.v1
https://doi.org/10.1158/1078-0432.22457063.v1
Autor:
Steven M. Albelda, Corey J. Langer, Melissa Culligan, Charles B. Simone, Keith A. Cengel, Luis J. Montaner, Paul Kennedy, Emmanouil Papasavvas, Kay See Tan, Jennifer H. Yearley, Leslie Litzky, Wei-Ting Hwang, Daniel F. Heitjan, Jing Sun, Sharyn I. Katz, Anil Vachani, Andrew R. Haas, Edmund K. Moon, Adri Recio, Susan Metzger, Joseph Friedberg, James P. Stevenson, Evan Alley, Daniel H. Sterman
Supplemental Tables 1-6 Supplemental Table 1. Results of some recent trials of chemotherapy in MPM. Supplemental Table 2. Post-Trial Therapies Supplemental Table 3. Characteristics of Patients Selected for Flow Cytometry Analysis Supplemental Table 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e2dbb2844eaa01ee4617c857fe022fb
https://doi.org/10.1158/1078-0432.22457066.v1
https://doi.org/10.1158/1078-0432.22457066.v1
Autor:
Steven M. Albelda, Corey J. Langer, Melissa Culligan, Charles B. Simone, Keith A. Cengel, Luis J. Montaner, Paul Kennedy, Emmanouil Papasavvas, Kay See Tan, Jennifer H. Yearley, Leslie Litzky, Wei-Ting Hwang, Daniel F. Heitjan, Jing Sun, Sharyn I. Katz, Anil Vachani, Andrew R. Haas, Edmund K. Moon, Adri Recio, Susan Metzger, Joseph Friedberg, James P. Stevenson, Evan Alley, Daniel H. Sterman
Additional Trial related information and methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d4ffca09b8061f1a4899f237a9a5a33
https://doi.org/10.1158/1078-0432.22457057
https://doi.org/10.1158/1078-0432.22457057
Autor:
Steven M. Albelda, Corey J. Langer, Melissa Culligan, Charles B. Simone, Keith A. Cengel, Luis J. Montaner, Paul Kennedy, Emmanouil Papasavvas, Kay See Tan, Jennifer H. Yearley, Leslie Litzky, Wei-Ting Hwang, Daniel F. Heitjan, Jing Sun, Sharyn I. Katz, Anil Vachani, Andrew R. Haas, Edmund K. Moon, Adri Recio, Susan Metzger, Joseph Friedberg, James P. Stevenson, Evan Alley, Daniel H. Sterman
Supplemental Figure 1. Immunoblots of Patient Serum before and after Therapy Supplemental Figure 2. Distribution of 1/Nab Titers for the 40 Patients Supplemental Figure 3. Distribution of the Day 2 serum levels of Interferon-alpha Supplemental Figure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5209115da30ff88797dbdbf0dda69401
https://doi.org/10.1158/1078-0432.22457060
https://doi.org/10.1158/1078-0432.22457060
Autor:
Robert H. Vonderheide, Michael D. Feldman, Elizabeth Veloso, Gregory L. Beatty, Barbara A. Vance, Michael H. Wexler, Michael S. Leibowitz, Lynn M. Schuchter, Angela DeMichele, Kevin R. Fox, Erica L. Carpenter, Carolyn E. Clark, Rosemarie Mick, Adri Recio, Susan M. Domchek
Supplementary Table 3 from Telomerase-Specific T-Cell Immunity in Breast Cancer: Effect of Vaccination on Tumor Immunosurveillance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22a7452a3f2c1099479c6246cefed8b6
https://doi.org/10.1158/0008-5472.22371399.v1
https://doi.org/10.1158/0008-5472.22371399.v1
Autor:
Robert H. Vonderheide, Michael D. Feldman, Elizabeth Veloso, Gregory L. Beatty, Barbara A. Vance, Michael H. Wexler, Michael S. Leibowitz, Lynn M. Schuchter, Angela DeMichele, Kevin R. Fox, Erica L. Carpenter, Carolyn E. Clark, Rosemarie Mick, Adri Recio, Susan M. Domchek
Supplementary Table 2 from Telomerase-Specific T-Cell Immunity in Breast Cancer: Effect of Vaccination on Tumor Immunosurveillance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11d7eb11eb9a9f735e9e79ca169a2434
https://doi.org/10.1158/0008-5472.22371402.v1
https://doi.org/10.1158/0008-5472.22371402.v1
Autor:
Robert H. Vonderheide, Michael D. Feldman, Elizabeth Veloso, Gregory L. Beatty, Barbara A. Vance, Michael H. Wexler, Michael S. Leibowitz, Lynn M. Schuchter, Angela DeMichele, Kevin R. Fox, Erica L. Carpenter, Carolyn E. Clark, Rosemarie Mick, Adri Recio, Susan M. Domchek
The human telomerase reverse transcriptase (hTERT) is nearly universally overexpressed in human cancer, contributes critically to oncogenesis, and is recognized by cytotoxic T cells that lyse tumors. CD8+ T cells specific for hTERT naturally occur in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c45308814b6a0e3a01c2fbd6e04456c
https://doi.org/10.1158/0008-5472.c.6496782
https://doi.org/10.1158/0008-5472.c.6496782
Autor:
Robert H. Vonderheide, Michael D. Feldman, Elizabeth Veloso, Gregory L. Beatty, Barbara A. Vance, Michael H. Wexler, Michael S. Leibowitz, Lynn M. Schuchter, Angela DeMichele, Kevin R. Fox, Erica L. Carpenter, Carolyn E. Clark, Rosemarie Mick, Adri Recio, Susan M. Domchek
Supplementary Table 1 from Telomerase-Specific T-Cell Immunity in Breast Cancer: Effect of Vaccination on Tumor Immunosurveillance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fe0cd1f73ccd74b986074ab71f77ff1
https://doi.org/10.1158/0008-5472.22371405.v1
https://doi.org/10.1158/0008-5472.22371405.v1
Autor:
Corey J. Langer, Steven M. Albelda, Daniel F. Heitjan, Jennifer H. Yearley, Keith A. Cengel, Joseph S. Friedberg, Adri Recio, Daniel H. Sterman, Melissa Culligan, Kay See Tan, Susan Metzger, Jing Sun, Anil Vachani, Sharyn I. Katz, Emmanouil Papasavvas, Wei-Ting Hwang, Paul G. Kennedy, Andrew R. Haas, James P. Stevenson, Evan W. Alley, Luis J. Montaner, Edmund K. Moon, Charles B. Simone, Leslie A. Litzky
Publikováno v:
Clinical Cancer Research. 22:3791-3800
Purpose: “In situ vaccination” using immunogene therapy has the ability to induce polyclonal antitumor responses directed by the patient's immune system. Experimental Design: Patients with unresectable malignant pleural mesothelioma (MPM) receive